Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Mandatory OSA treatment for truckers lowers insurance costs

Key clinical point: Mandatory testing and treatment for OSA in truckers may be cost effective

Major finding: Truckers treated for OSA saw mean insurance savings of $441 per month in non-OSA–related costs.

Study details: A retrospective cohort study of records from more than 3,000 truckers screened for suspected OSA in a large commercial fleet.

Disclosures: The National Surface Transportation Safety Center for Excellence and Harvard University sponsored the study. Two coauthors disclosed extensive device and pharmaceutical industry funding.